PRAMIPEXOLE SCP pramipexole dihydrochloride monohydrate 1.5 mg tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

pramipexole dihydrochloride monohydrate, Quantity: 1.5 mg

Disponible desde:

Southern Cross Pharma Pty Ltd

Designación común internacional (DCI):

pramipexole dihydrochloride monohydrate

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate

Vía de administración:

Oral

Unidades en paquete:

100's

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

The treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Resumen del producto:

Visual Identification: white, round tablets, marked on one side with the letter 'E', scored on the other side, with no defects and dimensions 6 mm diameter and 3 mm thickness; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2015-11-17